Oregon legislation · 2026 Legislative Measures
Oregon SB1571: Relating to consumer products for adults; and prescribing an effective date.
Status: Chaptered, April 6, 2026
Digest: This Act changes some laws that apply to products with tobacco or nicotine. (Flesch Readability Score: 63.4). Adds a definition of "nicotine" and expands the definition of "tobacco products." [ Repeals existing criminal prohibition on the sale of inhalant delivery systems or tobacco products to a person under 21 years of age and replaces the repealed law with a civil prohibition enforced by the Oregon Health Authority. Authorizes imposition of civil penalties for violations. ] [ Establishes a civil prohibition on providing, without compensation, inhalant delivery systems or tobacco products. ] [ Authorizes the authority to adopt rules to administer certain laws that apply to inhalant delivery systems and tobacco products. ] [ Requires any sale of tobacco products, cigarettes, inhalant delivery systems or smokeless tobacco products to occur in person at licensed premises. ] Takes effect on the 91st day following adjournment sine die.
What the bill says
From the enrolled text, March 3, 2026:
83rd OREGON LEGISLATIVE ASSEMBLY--2026 Regular Session Senate Bill 1571 Sponsored by Senator REYNOLDS; Senators JAMA, NERON MISSLIN, PATTERSON, SOLLMAN, Representatives ANDERSEN, HUDSON, ISADORE, PHAM H, WATANABE (Presession filed.) CHAPTER ................................................. Relating to consumer products for adults; amending ORS 431A.175; and prescribing an effective date. SECTION 1. ORS 431A.175 is amended to read: 431A.175. (1) As used in this section and ORS 431A.183: (a)(A) "Inhalant delivery system" means: (i) A device that can be used to deliver nicotine or cannabinoids in the form of a vapor or aerosol to a person inhaling from the device; or (ii) A component of a device described in this subparagraph or a substance in any form sold for the purpose of being vaporized or aerosolized by a device described in this subparagraph, whether or not the component or substance is sold separately [or is not sold separately]. (B) "Inhalant delivery system" does not include: (i) Any product that has been approved by the United States Food and Drug Administration for sale as a tobacco cessation product or for any other therapeutic purpose, if the product is marketed and sold solely for the approved purpose; and (ii) Tobacco products. (b) "Nicotine" means any form of the chemical nicotine, regardless of whether the chemical is naturally or synthetically derived, including any salt, complex, alkaloid or analog of …